Alx Oncology Holdings (ALXO) Non-Current Assets (2019 - 2026)

Alx Oncology Holdings' Non-Current Assets history runs 8 years deep, the most recent figure standing at $32.8 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 78.38% year-over-year to $32.8 million; the TTM figure through Mar 2026 stood at $67.4 million (down 37.36% YoY), while the FY2025 annual figure was $8.3 million, down 38.02% from the prior year.
• Non-Current Assets came in at $32.8 million for Q1 2026 at Alx Oncology Holdings, up from $8.3 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $53.9 million in Q4 2023 to a low of $8.3 million in Q4 2025.
• A 5-year average of $29.4 million and a median of $29.2 million in 2022 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets jumped 7130.02% in 2022 and sank 78.08% in 2025, its largest moves.
• Alx Oncology Holdings' Non-Current Assets stood at $35.5 million in 2022, then surged by 51.73% to $53.9 million in 2023, then plunged by 75.09% to $13.4 million in 2024, then tumbled by 38.02% to $8.3 million in 2025, then soared by 293.85% to $32.8 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $32.8 million, $8.3 million, and $16.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison